← Back to Search

Active TMS for Post-Traumatic Stress Disorder

N/A

Waitlist Available

Research Sponsored by Rush University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 1 month follow up

Awards & highlights

Study Summary

This trial aims to see if adding a non-invasive brain stimulation technique called intermittent theta burst stimulation (iTBS) to regular intensive PTSD treatment can help improve treatment outcomes for veterans with PTSD who are attending

Who is the study for?

This trial is for veterans enrolled in a 2-week intensive outpatient program for PTSD who haven't seen symptom improvement in the first week. Specific eligibility details are not provided, but typically participants must meet certain health and condition-specific criteria.Check my eligibility

What is being tested?

The study tests if adding intermittent theta burst stimulation (iTBS) to regular treatment helps improve PTSD symptoms. iTBS will be applied to a brain region called the right dorsolateral prefrontal cortex during the second week of treatment, compared with a sham (placebo-like) procedure.See study design

What are the potential side effects?

While specific side effects are not listed, TMS can generally cause discomfort at the stimulation site, headache, lightheadedness, or seizures in rare cases. The sham procedure should have minimal to no side effects.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 1 month follow up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 1 month follow up

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

PTSD Checklist for DSM-5 (PCL-5)

Secondary outcome measures

Patient Health Questionnaire-9 (PHQ-9)

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Active TMSActive Control1 Intervention

Group II: ShamPlacebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor

422 Previous Clinical Trials

163,501 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals over the age of 30 being sought for enrollment in this research study?

"The trial seeks participants who are above 18 years and below 65 years old."

Answered by AI

Which specific criteria must individuals meet in order to be eligible for participation in this clinical study?

"Eligible candidates for this medical research must be aged between 18 and 65 years old and have a diagnosis of post-traumatic stress disorder. The study is accepting enrollment from a maximum of 30 participants."

Answered by AI

Are there any available positions for participants in this research study?

"As per clinicaltrials.gov, recruitment for this specific study is currently closed. The trial was initially listed on 1/11/2022 and last modified on 2/14/2024. While this particular trial is not actively enrolling participants, there are a total of 327 other trials seeking eligible candidates presently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

TMS for Veterans Attending a 2-week Intensive Outpatient Program for PTSD

2022. "TMS for Veterans Attending a 2-week Intensive Outpatient Program for PTSD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06271733.